Fermer le menu


APCure is a company developing Immunotherapy products based on BacVac, a highly innovative technology that uses a live, harmless and bioengineered bacterial vector.

This technology is unique, as it combines the great efficacy and safety with the simplicity of the pharmaceutical development. It was ideated, developed and patented by the TheREx academic laboratory in Grenoble (France), under the lead of Pr B. Polack and Pr. B. Toussaint. Using this technology, APCure will generate new products for the treatment of many types of tumors and infectious diseases, aiming to become a leading developer of active immunotherapy products.


Strategic application domain: Human Medicine

Application market: Infectious Diseases, Oncology

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Cell Therapy - Stem cells - Cell Biology - Biobanking, Vaccine

Created on march 12th, 2012 - 0 employees



282, rue André Philip 69003 LYON



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.